Hefei Lifeon Pharmaceutical's subsidiary has obtained acceptance for the application for registration and listing permit of polyvinyl alcohol eye drops.
Cubic Pharmaceuticals (003020.SZ) announced that its holding subsidiary Hefei Nuo Ruite Pharmaceutical Co., Ltd. has recently received the "Acceptance Notice" for the registration and listing application for polyvinyl alcohol eye drops issued by the National Medical Products Administration.
Hefei Lifeon Pharmaceutical (003020.SZ) announced that its holding subsidiary, Hefei Nuorite Pharmaceutical Co., Ltd., has received the "Acceptance Notice" for the application for registration and listing of polyvinyl alcohol eye drops issued by the National Medical Products Administration.
Polyvinyl alcohol eye drops can be used as a lubricant to prevent or treat symptoms such as dryness, foreign body sensation, eye fatigue, and improve dryness in the eyes. It is suitable for conditions such as dry eye syndrome, eye strain, discomfort caused by wearing contact lenses, prolonged eye use, and dry environments. The product that has been listed belongs to Category B over-the-counter drugs (OTC). This application is for a generic version of a drug that is already on the market domestically and is being concurrently applied for OTC status.
Related Articles
PW MEDTECH (01358) spent HKD 196,350 on July 21 to repurchase 187,000 shares.
On July 21st, KIMOU ENVIRON (06805) spent HKD 645,000 to buy back 206,000 shares.
Guangdong High Dream Intellectualized Machinery (300720.SZ) plans to repurchase company shares with an amount ranging from 50 million to 100 million yuan.
PW MEDTECH (01358) spent HKD 196,350 on July 21 to repurchase 187,000 shares.
On July 21st, KIMOU ENVIRON (06805) spent HKD 645,000 to buy back 206,000 shares.
Guangdong High Dream Intellectualized Machinery (300720.SZ) plans to repurchase company shares with an amount ranging from 50 million to 100 million yuan.
RECOMMEND
